Clinical efficacy and safety of apatinib combined with S-1 in advanced esophageal squamous cell carcinoma

Background Esophageal cancer is a very common malignant tumor in China, especially esophageal squamous cell carcinoma (ESCC), but there is currently no effective treatment for patients after first-line chemotherapy failure. Apatinib has shown promising outcomes in treatment with various solid tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Jian, Lei, Junmei, Yu, Junyan, Zhang, Chengyan, Song, Xuefeng, Zhang, Ninggang, Wang, Yusheng, Zhang, Suxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Phase II Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066276/
https://www.ncbi.nlm.nih.gov/pubmed/31650447
http://dx.doi.org/10.1007/s10637-019-00866-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7066276/
https://www.ncbi.nlm.nih.gov/pubmed/31650447
http://dx.doi.org/10.1007/s10637-019-00866-5

Ejemplares similares